1.Comparative Study on the Antineoplastic Effect of Non-alkaloid Components from Gelsemium Elegans Benth in Vitro and in Vivo
Minghong ZHAO ; Tao GUO ; Qingchun ZHAO
China Pharmacy 2005;0(23):-
OBJECTIVE:To evaluate the antineoplastic effects of non-alkaloid components from Gelsemium elegans Benth in vitro and in vivo and to study the correlation between antineoplastic effects and toxicity.METHODS:The cell proliferation inhibition effect of every component on tumor cells in vitro was studied by MTT method,the antineoplastic activity of non-alkaloid components were comprehensively evaluated through acute toxicity testing on mice,the inhibition effect test on H 22 of liver tumor-bearing mice and the test on the effect on immunizing index.RESULTS:The antineoplastic activity of non-alkaloid in Gelsemium elegans in vitro surpassed alkaloid,and in which the component 2 could significantly inhibit H 22 tumor growth in mice,the thymus gland indexes were significantly higher in treatment group than non-treatment tumor-bearing mice.However,the other components showed no significant effect on tumor growth and those with stronger toxicity showed no antineoplastic activity.CONCLUSIONS:The non-alkaloid components from Gelsemium elegans Benth show anti-neoplastic effects and enhancement property on immune function,however,its antineoplastic effects in vitro and in vivo have no obvious correlation with toxicity.
2.Application of uniform-design method used to select best proportion of ingredients in Danxintong
Peng GAO ; Ningfei AN ; Minghong ZHAO ; Yulan LIU ;
Chinese Traditional and Herbal Drugs 1994;0(02):-
Object To define the optimal proportion of four ingredients in Danxintong (DXT). Methods Uniform design method combined with pharmacodynamics (Rat acute myocardial ischemia model was used in this study) was used. Results The optimal proportion and components of DXT (Composed of Rhizoma Chuanxiong, Rhizoma Cyperi, Borneolum Syntheticum, and paeonol) were 5∶ 1.7∶ 1.4∶ 4.4; DXT 138 mg/kg could obviously inhibit acute myocardial ischemia of rats induced by iso prenaline (Iso) and pituiturin (Pit). DXT has antimyocardial ischemia effects in preliminary experimental studies. Conclusion Uniform design method is an effective method to define the optimal proportion of ingredients in DXT;
3.Integron-mediated Antibiotic Multiresistance in Acinetobacter baumannii Clinical Isolates
Jingping ZHANG ; Bo ZHAO ; Minghong LI ; Wan ZHU ; Baiyi CHEN
Chinese Journal of Nosocomiology 1994;0(01):-
OBJECTIVE To determine the category of gene cassettes in type 1 integrons of multi-resistant Acinetobacter baumannii from Shenyang.METHODS Fifty clinical isolates were collected from the First Affiliated Hospital of China Medical University and K-B test was used to determine the susceptibility and the results were read based on Clinical and Laboratory Standards Institute(CLSI) of the USA.PCR was used to detect the existance of integron,and DNA sequencing was also required.RESULTS There are thirty-two isolates positive for integron.Sequencing analysis showed the integrons carried two different known genes(arr-3 and aacA4).CONCLUSIONS The results show the potential risk of integron dissemination among different strains of A.baumannii.
4.Study on physicochemical properties of storax ?-cyclodextrin inclusion complex
Hongtao SONG ; Tao GUO ; Minghong ZHAO ; Ruhua ZHANG ; Xian LI ;
Chinese Traditional and Herbal Drugs 1994;0(06):-
Object To study the phsiochemical properties of storax ? cyclodextrin (? CD) inclusion complex Methods The inclusion complex was identified by the methods of TLC, X ray powder diffractometry and IR The solubility and dissolution rate of cinnamic acid in inclusion complex were investigated by HPLC Results The TLC showed that the main composition of storax had no change before and after being included by ? CD The spectra of X ray powder diffractometry and IR of the inclusion complex were remarkably different from those of storax and storax ? CD mixture It was shown a great improvement of the solubility and dissolution rate of cinnamic acid in the inclusion complex in 0 1 mol/L HCl, pH 6 6 and pH 7 5 phosphate buffer solution Conclusion The storax ? CD inclusion complex exhibits some new physical characteristics and its physiochemical properties are greatly changed comparing with those of storax
5.Development of inflammation and coagulation disorders in sepsis
Yuanlu HOU ; Ruru ZHAO ; Lei GAO ; Qifeng LI ; Zheng YAO ; Minghong LI
Acta Laboratorium Animalis Scientia Sinica 2024;32(2):230-237
Objective To investigate changes in coagulation function and inflammation levels during sepsis.Methods A rat model of sepsis was established using the multiple infection sepsis model(MIM)based on cecal ligation and puncture.Forty-eight male Sprague-Dawley rats were assigned randomly to the following groups:control group,sham group,4 h sepsis group,8 h sepsis group,12 h sepsis group,and 16 h sepsis group(n=8 per group).Inflammatory markers and coagulation-related indicators were measured by enzyme-linked immunosorbent assay and coagulation analysis.Results(1)Lipopolysaccharide(LPS)and interleukin-6(IL-6)levels were significantly higher in the model rats at all time points compared with the sham group(P<0.001).LPS and IL-6 levels increased gradually with disease progression,with no further changes in LPS after 12 hours.(2)Prothrombin time(PT)was significantly prolonged in the middle and late stages of the sepsis model,starting from 8,compared with the sham group(P<0.01).(3)Partially activated prothrombin time(APTT)time was significantly prolonged in the 8,12,and 16 h groups compared with the sham group(P<0.05,P<0.01).APTT gradually lengthened from 8 h,but approached control levels thereafter.(4)Fibrinogen(Fbg)content was significantly higher in all sepsis groups,except for the 8 h group,compared with the sham group(P<0.01).(5)Fibrin degradation products(FDP)differed significantly between the control and sham groups(P<0.01),but not between the sham and sepsis groups.(6)Antithrombin-Ⅲ(AT-Ⅲ)levels decreased significantly throughout each stage of sepsis progression compared with the sham group(P<0.01),and AT-Ⅲ showed a downward trend with the course of disease,with significant differences among the 4,8,and 16 h groups.Conclusions The MIM rat model can reflect the development of inflammatory and blood coagulation disorders and their relationship during the course of sepsis,and may thus provide a good foundation for further research into the disease course of sepsis.
6.Research progress on ferroptosis in the treatment of bladder cancer
Jingping QIU ; Lugang ZHU ; Yuanwei CHEN ; Minghong ZHOU ; Yuwan ZHAO ; Jianjun LIU
Journal of Modern Urology 2024;29(9):830-835
Ferroptosis is a new programmed cell death dependent on iron ions.Ferroptosis can be induced by endogenous or exogenous pathways,and cells exhibit specific cell morphological signs and are regulated by a variety of molecular mechanisms.In recent years,more and more studies have shown that ferroptosis plays an important role in the treatment of cancer.This article summarizes the mechanism of ferroptosis in bladder cancer and the regulation of cancer cells,as well as the role of ferroptosis-related factors,non-coding RNA regulation,N6-methyladenosine(m6A),amino acid metabolism and autophagy dependent ferroptosis in the growth and proliferation of bladder cancer,with a view to provide new strategies for the treatment of bladder cancer.
7.Predictive values of interleukin-2 and soluble interleukin 2 receptor in serum and cerebrospinal fluid for intracranial infection after craniotomy
Xunhui YUAN ; Hongyan ZHAO ; Minghong LI ; Mei'e YUAN ; Jianguo WANG ; Hang XIAO ; Gaoling SUN ; Jianyi NIU ; Yun'an BAI
Chinese Journal of Neuromedicine 2017;16(10):1052-1055
Objective To evaluate the predictive values of interleukin (IL)-2 and soluble interleukin 2 receptor (sIL-2R) in the serum and cerebrospinal fluid in early intracranial infection,and provide the reference for choosing diagnostic markers of early intracranial infection after craniotomy.Methods From January 2014 to January 2016,36 patients with intracranial infection after craniotomy in our hospital were chosen as infection group,and 45 patients without intracranial infection were as non-infection group.The body temperature and levels ofcerebrospinaI fluid glucose,blood white blood cell (WBC),cerebrospinal fluid WBC,serum IL-2,cerebrospinal fluid IL-2,serum sIL-2R and cerebrospinal fluid sIL-2R were compared between the two groups.The diagnosis values of IL-2 and sIL-2R in serum and cerebrospinal fluid in intracranial infection were analyzed by receiver operating characteristic curve (ROC) curve.The sensitivity and specificity of IL-2 and sIL-2R in the serum and cerebrospinal fluid in intracranial infection were compared between the two groups.Results The body temperature of the two groups showed no statistical difference (P>0.05).As compared with those in the non-infection group,the glucose of cerebrospinal fluid in the infection group significantly decreased (P<0.05),the blood WBC,cerebrospinal fluid WBC,serum IL-2,cerebrospinal fluid IL-2,serum sIL-2R and cerebrospinal fluid sIL-2R in the infection group significantly increased (P<0.05).The areas under of curve for body temperature,glucose of cerebrospinal fluid,blood WBC,cerebrospinal fluid WBC,serum IL-2,cerebrospinal fluid IL-2,serum sIL-2R and cerebrospinal fluid sIL-2R,respectively,were 0.671,0.718,0.698,0.741,0.714,0.927,0.722 and 0.968;the sensitivity of those indexes,respectively,was 61.1%,63.9%,69.4%,91.7%,88.9%,91.7%,86.1%and94.4%;the specificityofthoseindexes,respectively,was 48.9%,82.2%,60.0%,55.6%,62.2%,88.9%,66.7% and 91.1%.Conclusion The IL-2 and sIL-2R levels in serum and cerebrospinal fluid have decided values in diagnosis of intracranial infection after craniotomy,but the sensitivity and specificity of IL-2 and sIL-2R in cerebrospinal fluid are higher than others.
8.Single-cell transcriptome analysis uncovers underlying mechanisms of acute liver injury induced by tripterygium glycosides tablet in mice
Qiuyan GUO ; Jiangpeng WU ; Qixin WANG ; Yuwen HUANG ; Lin CHEN ; Jie GONG ; Maobo DU ; Guangqing CHENG ; Tianming LU ; Minghong ZHAO ; Yuan ZHAO ; Chong QIU ; Fei XIA ; Junzhe ZHANG ; Jiayun CHEN ; Feng QIU ; Jigang WANG
Journal of Pharmaceutical Analysis 2023;13(8):908-925
Tripterygium glycosides tablet(TGT),the classical commercial drug of Tripterygium wilfordii Hook.F.has been effectively used in the treatment of rheumatoid arthritis,nephrotic syndrome,leprosy,Behcet's syndrome,leprosy reaction and autoimmune hepatitis.However,due to its narrow and limited treatment window,TGT-induced organ toxicity(among which liver injury accounts for about 40%of clinical reports)has gained increasing attention.The present study aimed to clarify the cellular and molecular events underlying TGT-induced acute liver injury using single-cell RNA sequencing(scRNA-seq)technology.The TGT-induced acute liver injury mouse model was constructed through short-term TGT exposure and further verified by hematoxylin-eosin staining and liver function-related serum indicators,including alanine aminotransferase,aspartate aminotransferase,alkaline phosphatase and total bilirubin.Using the mouse model,we identified 15 specific subtypes of cells in the liver tissue,including endothelial cells,hepatocytes,cholangiocytes,and hepatic stellate cells.Further analysis indicated that TGT caused a significant inflammatory response in liver endothelial cells at different spatial locations;led to marked inflammatory response,apoptosis and fatty acid metabolism dysfunction in hepatocytes;activated he-patic stellate cells;brought about the activation,inflammation,and phagocytosis of liver capsular macrophages cells;resulted in immune dysfunction of liver lymphocytes;disturbed the intercellular crosstalk in liver microenvironment by regulating various signaling pathways.Thus,these findings elaborate the mechanism underlying TGT-induced acute liver injury,provide new insights into the safe and rational applications in the clinic,and complement the identification of new biomarkers and ther-apeutic targets for liver protection.
9.Assessment of mortality burden and economic loss attributed to long-term PM 2.5 exposure in the Beijing-Tianjin-Hebei area
Wenjing WU ; Xiaocui YANG ; Minghong YAO ; Gonghua WU ; Jiayue XU ; Xing ZHAO ; Juying ZHANG
Chinese Journal of Epidemiology 2020;41(9):1471-1476
Objective:To accurately estimate the health burden and corresponding economic loss attributed to PM 2.5 pollution in the Beijing-Tianjin-Hebei (BTH) area in China in 2015. Method:By using satellite-retrieved PM 2.5 concentration data and population data provided by NASA (the spatial resolution was 1 km×1 km), this study estimated excess mortality attributed to long-term PM 2.5 exposure in BTH area in 2015 based on Global Exposure Mortality Model (GEMM). Besides, Value of Statistic Life (VSL) method was used to evaluate the corresponding health economic loss. Result:In BTH area, the population-weighted average PM 2.5 concentration during 2012-2014 was 46.25 μg/m 3, and 56.6% of total population lived in the area where annual average PM 2.5 concentration exceeded Grade Ⅱ of National Ambient Air Quality Standard in China (35 μg/m 3); The PM 2.5-related premature deaths amounted to 193.8 thousand (95 %CI: 140.9 thousand-233.3 thousand), Beijing, Tianjin, Baoding, Shijiazhuang, and Handan were the top five cities with high incidences of PM 2.5-related premature deaths; The corresponding health economic loss was about 35.934 billion (95 %CI: 26.099 billion - 43.255 billion) RMB, accounting for 0.70% (95 %CI: 0.51%-0.85%) of the area’s GDP in 2015, Beijing, Tianjin, Baoding, Shijiazhuang, and Cangzhou were the top five cities with high health economic loss. Conclusions:PM 2.5 pollution has caused severe disease and economic burden in BTH area. Its spatial distribution suggested that it is particularly necessary to develop the air pollution prevention and control policies for key cities.
10.A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China
Juan DU ; Xin QIU ; Jiayao NI ; Qiaoli WANG ; Fan TONG ; Huizi SHA ; Yahui ZHU ; Liang QI ; Wei CAI ; Chao GAO ; Xiaowei WEI ; Minbin CHEN ; Zhuyin QIAN ; Maohuai CAI ; Min TAO ; Cailian WANG ; Guocan ZHENG ; Hua JIANG ; Anwei DAI ; Jun WU ; Minghong ZHAO ; Xiaoqin LI ; Bin LU ; Chunbin WANG ; Baorui LIU
Chinese Journal of Oncology 2024;46(11):1038-1048
Objective:To observe and evaluate the clinical efficacy and safety of albumin-bound paclitaxel as first-line treatment for patients with advanced pancreatic cancer in China, and to explore the prognosis-related molecules in pancreatic cancer based on next-generation sequencing (NGS) of tumor tissues.Methods:From December 2018 to December 2020, patients with locally advanced or metastatic pancreatic cancer were recruited to accept albumin-bound paclitaxel as first-line treatment in the oncology departments of 24 hospitals in East China. The primary endpoints were overall survival (OS) and treatment related adverse events, and the secondary endpoint was progression-free survival (PFS). Adverse effects were graded using Common Terminology Criteria for Adverse Events 5.0 (CTCAE 5.0). NGS sequencing on the primary or metastatic tissue samples of pancreatic cancer obtained through surgical resection or biopsy was performed.Results:This study recruited 229 patients, including 70 patients with locally advanced pancreatic cancer (LAPC) and 159 patients with metastatic pancreatic cancer (mPC). The disease control rate was 79.9% and the objective response rate is 36.3%.The common adverse effects during treatment were anaemia (159 cases), leucopenia (170 cases), neutropenia (169 cases), increased aminotransferases (110 cases), and thrombocytopenia (95 cases), and the incidence of grade 3-4 neutropenia is 12.2% (28/229). The median follow-up time was 21.2 months (95% CI: 18.5-23.1 months). The median PFS (mPFS) was 5.3 months (95% CI: 4.37-4.07 months) and the median OS (mOS) was 11.2 months (95% CI: 9.5-12.9 months). The mPFS of patients with LAPC was 7.4 months (95% CI: 6.6-11.2 months), and their mOS was 15.5 months (95% CI: 12.6-NA months). The mPFS of patients with mPC was 3.9 months (95% CI: 3.4-5.1 months), and their mOS was 9.3 months (95% CI: 8.0-10.8 months). Multivariate Cox regression analysis showed that clinical stage ( HR=1.47, 95% CI: 1.06-2.04), primary tumor site ( HR=0.64, 95% CI: 0.48-0.86), Eastern Cooperative Oncology Group Performance Status (ECOG PS) score ( HR=2.66, 95% CI: 1.53-4.65), and whether to combine radiotherapy ( HR=0.65, 95% CI: 0.42-1.00) were independent influencing factors for the PFS of these patients. The primary tumor site ( HR=0.68, 95% CI: 0.48-0.95), ECOG score ( HR=5.82, 95% CI: 3.14-10.82), and whether to combine radiotherapy ( HR=0.58, 95% CI: 0.35-0.96) were independent influencing factors of the OS of these patients. The most frequent gene mutations in these advanced stage pancreatic patients were KRAS (89.66%), TP53 (77.01%), CDKN2A (32.18%), and SMAD4 (21.84%) by NGS of tumor tissues from 87 pancreatic cancer patients with sufficient specimens. Further analysis revealed that mutations in CDKN2B, PTEN, FGF6, and RBBP8 genes were significantly associated with an increased risk of death ( P<0.05). Conclusion:Albumin-bound paclitaxel as first-line treatment demonstrated feasible anti-tumor efficacy and manageable safety for patients with advanced pancreatic cancer in China.